Key takeaways
Resiliency ReportFebruary 10, 2026
We’re seeing increasing disruption in the sterile surgical gown and drape market.
We have traced these fluctuations to a combination of recent recalls affecting certain sterile SMS and meltblown nonwoven textile products, a domino effect from distributor allocations, and raw material and capacity constraints that are creating near-term gaps.
These events have led to rising backorders, tighter allocation limits, and increased last-minute substitution requests across health systems.
According to market intelligence, these issues aren’t expected to fully resolve until at least April, with some estimates through July.
If your facility is facing gaps, Cato can help with short-term coverage and substitution planning.
We are providing Immediate inventory across multiple OEMs and brands:
For teams impacted by the current recall activity, Cato can review functional cross-overs where appropriate.
AAMI Level 3 substitutes: Where name-brand items are constrained, Cato has identified Level 3 alternatives available in bulk that meet protection requirements while reducing unit cost relative to typical premium brands.
We provide real-time availability confirmation. Stock changes quickly. If you have a product need, send the SKU, specifications, and quantities, and Cato will confirm real-time availability and respond with specific matches or viable substitutes.
Our Risk Radar tool is worth exploring as it provides a live view of impacted SKUs and constrained categories with active availability.
If you’re not finding what you need through usual channels, send the request anyway. Cato is known for sourcing coverage options quickly.

